Cytokine-induced cytotoxic function expressed by lymphocytes of the innate immune system: Distinguishing characteristics of NK and LAK based on functional and molecular markers

被引:21
作者
Frederick, M
Grimm, E
Krohn, E
Smid, C
Yu, TK
机构
[1] UNIV TEXAS, MD ANDERSON CANCER CTR, DEPT TUMOR BIOL 79, HOUSTON, TX 77030 USA
[2] UNIV TEXAS, MD ANDERSON CANCER CTR, DEPT HEAD & NECK SURG, HOUSTON, TX 77030 USA
关键词
D O I
10.1089/jir.1997.17.435
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Several molecular events are now identifiable during the activation, recognition, and killing by natural killer (NK) cells that are distinct from those differentiated in response to cytokines during the generation of lymphokine-activated killer (LAK) cells or during lymphocyte proliferation. Because LAK and MHC-unrestricted killing activities also include the prototypic NK targets as part of their broad recognition spectra, accurate identification of the complete function being studied is critical. In many publications, past and present, only NK-sensitive target cells were used (K562, Molt-4, others), and, therefore, the results do not necessarily indicate whether the effecters are NK or have differentiated into LAK cells. Such a consideration becomes critical when the effecters are grown in interleukin-2 (IL-2), and an attempt is made to define receptor recognition, signal transduction pathways, and specificity at the molecular level. In some instances, effector cells are likely to have stopped, therefore merely expressing NK activity, and have also acquired LAK function. The identified receptors may not have been unique to NK cells or NK function. Not until the targets employed are also confirmed to be NK sensitive, and the effecters do not kill NK-resistant targets can the results of molecular studies be proposed to represent aspects unique to NK. Reports of the use of IL-2-expanded NK clones are most likely providing data concerning the biology of LAK and not of classic NK. The classic NK activity surveying our blood apparently performs an important function, including the ability to respond rapidly to certain cytokines and to acquire additional functions and receptors for use in destroying a vast array of target cells. It is critical for scientists to appreciate the functional distinctions and to identify the molecules and pathways unique to each of these curious cytolytic systems.
引用
收藏
页码:435 / 447
页数:13
相关论文
共 124 条
[1]   THE HUMAN HOX GENE FAMILY [J].
ACAMPORA, D ;
DESPOSITO, M ;
FAIELLA, A ;
PANNESE, M ;
MIGLIACCIO, E ;
MORELLI, F ;
STORNAIUOLO, A ;
NIGRO, V ;
SIMEONE, A ;
BONCINELLI, E .
NUCLEIC ACIDS RESEARCH, 1989, 17 (24) :10385-10402
[2]   INTERLEUKIN-7 ENHANCES CYTOLYTIC LYMPHOCYTE-T GENERATION AND INDUCES LYMPHOKINE-ACTIVATED KILLER-CELLS FROM HUMAN PERIPHERAL-BLOOD [J].
ALDERSON, MR ;
SASSENFELD, HM ;
WIDMER, MB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (02) :577-587
[3]  
ANEL A, 1994, J BIOL CHEM, V269, P9506
[4]  
ARMANT M, 1995, IMMUNOLOGY, V85, P331
[5]   COOPERATION OF NATURAL-KILLER-CELL STIMULATORY FACTOR INTERLEUKIN-12 WITH OTHER STIMULI IN THE INDUCTION OF CYTOKINES AND CYTOTOXIC CELL-ASSOCIATED MOLECULES IN HUMAN T-CELLS AND NK-CELLS [J].
ASTEAMEZAGA, M ;
DANDREA, A ;
KUBIN, M ;
TRINCHIERI, G .
CELLULAR IMMUNOLOGY, 1994, 156 (02) :480-492
[6]   STUDIES OF THE MECHANISM OF NATURAL-KILLER (NK) DEGRANULATION AND CYTOTOXICITY [J].
ATKINSON, EA ;
GERRARD, JM ;
HILDES, GE ;
GREENBERG, AH .
JOURNAL OF LEUKOCYTE BIOLOGY, 1990, 47 (01) :39-48
[7]   STIMULATION OF FC-GAMMA-RIIIA RESULTS IN PHOSPHOLIPASE C-GAMMA-1 TYROSINE PHOSPHORYLATION AND P56(LCK) ACTIVATION [J].
AZZONI, L ;
KAMOUN, M ;
SALCEDO, TW ;
KANAKARAJ, P ;
PERUSSIA, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (06) :1745-1750
[8]  
Azzoni L, 1996, J IMMUNOL, V157, P3235
[9]   INTERLEUKIN-12 (IL-12) INDUCES TYROSINE PHOSPHORYLATION OF JAK2 AND TYK2 - DIFFERENTIAL USE OF JANUS FAMILY TYROSINE KINASES BY IL-2 AND IL-12 [J].
BACON, CM ;
MCVICAR, DW ;
ORTALDO, JR ;
REES, RC ;
O'SHEA, JJ ;
JOHNSTON, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) :399-404
[10]  
BECKNER SK, 1988, J IMMUNOL, V140, P208